Organogenesis Holdings Inc. (ORGO) Financials

ORGO Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 460.0 million 181.4 million
2023-09-30 462.6 million 185.8 million
2023-06-30 450.3 million 179.0 million
2023-03-31 446.1 million 182.4 million

ORGO Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 7.3 million 2.4 million
2023-09-30 10.8 million 2.4 million
2023-06-30 1.1 million 2.3 million
2023-03-31 -12.6 million 1.9 million

ORGO Net Income

Graph available only for supporters. Become a supporter to see it.
DateNet Income
2023-12-31 -568000
2023-09-30 3.2 million
2023-06-30 5.3 million
2023-03-31 -3.0 million

ORGO Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 104.3 million - 53.1 million
2023-09-30 98.2 million - 57.4 million
2023-06-30 88.9 million - 55.8 million
2023-03-31 88.7 million - 52.5 million

ORGO Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 131.9 million
2023-09-30 133.4 million
2023-06-30 133.1 million
2023-03-31 131.1 million

ORGO Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 3.3 million 11.8 million 61.4 million -
2023-09-30 6.0 million 10.5 million 64.2 million -
2023-06-30 7.5 million 10.9 million 70.3 million -
2023-03-31 7.6 million 11.2 million 73.8 million -

ORGO Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 99.7 million 31.9 million
2023-09-30 108.5 million 25.8 million
2023-06-30 117.3 million 26.3 million
2023-03-31 107.6 million 26.6 million

ORGO

Price: $2.35

52 week price:
1.80
4.71

Earnings Per Share: 0.04 USD

P/E Ratio: 33.30

Exchange: NCM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Volume: 317113

Market Capitalization: 380.1 million

Links: